MENDITTO, ENRICA
 Distribuzione geografica
Continente #
AS - Asia 5.438
EU - Europa 4.929
NA - Nord America 4.615
SA - Sud America 824
AF - Africa 179
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.999
Nazione #
US - Stati Uniti d'America 4.395
SG - Singapore 3.131
RU - Federazione Russa 2.484
CN - Cina 1.118
IT - Italia 849
BR - Brasile 675
HK - Hong Kong 492
VN - Vietnam 360
NL - Olanda 342
DE - Germania 336
FI - Finlandia 266
GB - Regno Unito 136
CA - Canada 132
IE - Irlanda 97
SE - Svezia 95
FR - Francia 69
IN - India 66
CI - Costa d'Avorio 64
UA - Ucraina 61
AR - Argentina 59
MX - Messico 54
BD - Bangladesh 50
ZA - Sudafrica 41
PL - Polonia 40
AT - Austria 36
ES - Italia 31
KR - Corea 31
EC - Ecuador 28
TR - Turchia 25
ID - Indonesia 23
JP - Giappone 19
IQ - Iraq 18
CO - Colombia 16
IR - Iran 15
LT - Lituania 14
MA - Marocco 14
BE - Belgio 13
KE - Kenya 13
PE - Perù 13
PK - Pakistan 13
PY - Paraguay 12
UY - Uruguay 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
AZ - Azerbaigian 8
DK - Danimarca 8
GR - Grecia 8
CH - Svizzera 7
DZ - Algeria 7
TN - Tunisia 7
EG - Egitto 6
IL - Israele 6
JM - Giamaica 6
SN - Senegal 6
VE - Venezuela 6
BG - Bulgaria 5
DO - Repubblica Dominicana 5
JO - Giordania 5
NP - Nepal 5
PH - Filippine 5
RO - Romania 5
SA - Arabia Saudita 5
CZ - Repubblica Ceca 4
MY - Malesia 4
CL - Cile 3
EE - Estonia 3
GT - Guatemala 3
HN - Honduras 3
LB - Libano 3
PA - Panama 3
TH - Thailandia 3
AL - Albania 2
BF - Burkina Faso 2
BS - Bahamas 2
CY - Cipro 2
DM - Dominica 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
GF - Guiana Francese 2
HT - Haiti 2
HU - Ungheria 2
LC - Santa Lucia 2
LY - Libia 2
MD - Moldavia 2
NI - Nicaragua 2
NO - Norvegia 2
PS - Palestinian Territory 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
UG - Uganda 2
YE - Yemen 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
BY - Bielorussia 1
Totale 15.969
Città #
Singapore 1.364
Moscow 582
Hong Kong 491
Chandler 447
Santa Clara 432
Ashburn 419
Beijing 379
Amsterdam 297
Naples 219
Millbury 193
Hefei 163
Los Angeles 158
Munich 143
Boston 124
Ho Chi Minh City 115
Princeton 108
Nanjing 104
Des Moines 99
Napoli 93
Lappeenranta 83
Buffalo 75
Lawrence 74
Redondo Beach 70
Ottawa 68
New York 67
Hanoi 66
São Paulo 66
Wilmington 57
Turku 55
The Dalles 52
Dallas 46
Jacksonville 45
Dong Ket 44
Nuremberg 42
Woodbridge 42
Frankfurt am Main 40
Helsinki 39
Milan 37
Warsaw 33
Nanchang 32
Rio de Janeiro 30
Mexico City 29
Atlanta 28
Chicago 28
Montreal 28
Seoul 28
Rome 27
Brooklyn 25
Hebei 25
Orem 25
Poplar 25
Shenyang 25
Stockholm 25
Tianjin 25
London 23
Falkenstein 22
Phoenix 22
Chennai 21
Redwood City 19
Washington 19
Houston 18
Seattle 18
Tokyo 18
Denver 17
Fairfield 15
Salerno 15
Sciacca 15
Toronto 15
Boardman 14
Haiphong 14
Jiaxing 14
Düsseldorf 13
Johannesburg 13
Belo Horizonte 12
Brasília 12
Porto Alegre 12
Vienna 12
Da Nang 11
Nairobi 11
Quito 11
Biên Hòa 10
Ninh Bình 10
Querétaro 10
Campinas 9
Curitiba 9
Montevideo 9
Mumbai 9
Salvador 9
San Francisco 9
Secaucus 9
Ankara 8
Baku 8
Bengaluru 8
Bologna 8
Changsha 8
Hải Dương 8
Lauterbourg 8
Manchester 8
Norwalk 8
Phủ Lý 8
Totale 8.015
Nome #
Evidence-based directions for polypharmacy revision: The experience gained by the campania reference site in the framework of the eip-aha action group A1 and of the friendd pilot study 192
[Evaluation of therapeutical appropriateness in psychiatric treatment of schizophrenia, by integrating computer data records with clinical audit results] 186
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 149
Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air® App 140
PERSISTENZA IN TERAPIA NEI SOGGETTI IN TRATTAMENTO CON FARMACI PER L' OSTEOPOROSI 136
Valutazione economica dello studio AVERT 132
Rates and reasons for lack of persistence with anti-osteoporotic drugs: analysis of the Campania Region Database 129
The Tosca Registry: An Ongoing, Observational, Multicenter Registry for Chronic Heart Failure 128
Drug Utilization and Measurement of Medication Adherence: A Real World Study of Psoriasis in Italy 125
ANALISI DEI PROFILI PRESCRITTIVI DEGLI ANTIPSICOTICI ATIPICI NELLA ASL CASERTA 125
Cost Analysis of an Intensive Care Unit 122
Osteoporosis drugs in real-world clinical practice: an analysis of persistence 116
La terapia farmacologica anti-osteoporotica: analisi della persistenza in Regione Campania. 116
Determinants of Non-Persistence to Antiosteoporotic Drugs by Using Administrative Database 115
How healthy is community-dwelling elderly population? Results from Southern Italy 114
Differences in drug use between men and women: An Italian cross sectional study 113
Impact of Cost- Containment Policies on Biosimilars Market 112
IMPATTO DELLE POLITICHE DI COST-CONTAINMENT SUL MERCATO DEI BIOSIMILARI 111
Next-generation ARIA care pathways for rhinitis and asthma: A model for multimorbid chronic diseases 110
Cost Analysis of an intensive care unit 109
Antibiotic prescription in Southern Italian outpatients: Real-world data analysis of prevalence, socioeconomic and sociodemographic variables and geographic variability 109
Consumption of biosimilar drugs in Campania Region in the years 2009 -2012 108
Cost-Effectiveness of Treatment Optimisation with Biomarkers for Immunotherapy in Solid Tumours: A Systematic Review 107
Gastroesophageal reflux disease (GERD) cost of care: Role of naive and relapsed symptoms in general practice 107
Le politiche di compartecipazione alla spesa farmaceutica 105
A Large-Scale Longitudinal Population-Based Study of Risk Reduction of Cardiovascular Complications in Patients on Bolus Insulin Analogues 105
Are you more concerned about or relieved by medicines? An explorative randomized study of the impact of telephone counseling by pharmacists on patients' beliefs regarding medicines and blood pressure control. 104
Valutazione economica dello studio IDEAL 103
Predictors of non-persistence on statin treatments in Italy: a retrospective cohort study in primary care. 103
LA VALUTAZIONE DELLA COMUNICAZIONE MEDICO-PAZIENTE: LA ESPERIENZA DELLA A.O.R.N. A CARDARELLI 103
Innovative Approaches to Active and Healthy Ageing: Campania Experience to Improve the Adoption of Innovative Good Practices 102
Prevalence of chronic obstructive pulmonary disease from administrative health services databases. 101
Lower incidence of macrovascular complications in patients on insulin glargine versus those on basal human insulins: A population-basad cohort study in Italy. 101
Baseline drug treatments as indicators of increased risk of COVID-19 mortality in Spain and Italy 101
Postvaccination SARS-CoV-2 Infections among Healthcare Professionals: A Real World Evidence Study 100
Influence of generic drugs on proton pump inhibitor prescription in primary care. 100
PPI general practitioners’prescribing in the treatment of acid-related disorders: the impact of generic PPI launch into the pharmaceutical market in Italy 100
Influenza dei farmaci generici sulle dinamiche prescrittive degli inibitori di pompa protonica in medicina generale 99
Three-Year Health Care Expenditures in Diabetic Patients Receiving Rapid-Acting Insulin Analogues Versus Those on Human Regular Insulin 98
In real clinical practice osteoporosis drugs are taken for a very short period: analysis of persistence in the Campania region 98
Prevalence of antibiotic prescription in southern Italian outpatients: real-world data analysis of socioeconomic and sociodemographic variables at a municipality level 98
Drug Utilization Pattern of Antibiotics: The Role of Age, Sex and Municipalities in Determining Variation 98
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice 97
Prescription Appropriateness of Drugs for Peptic Ulcer and Gastro-Esophageal Reflux Disease: Baseline Assessment in the LAPTOP-PPI Cluster Randomized Trial 97
Imaging tests in staging and surveillance of early breast cancer in Italy. changes in routine clinical practice and costs implications 97
AC4 - RETROSPECTIVE ANALYSIS OF INAPPROPRIATE MEDICATION PRESCRIPTION INDICATORS IN ELDERLY POPULATION IN ITALY 97
Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing 97
Assessment of surgeon communication skills from the patient perspective: A national evaluation using the Communication Assessment Tool 97
Lower rate of cardiovascular complications in patients on bolus insulin analogues: a retrospective population-based cohort study. 96
Cost analysis of anti-osteoporotic drugs in real-world clinical practice 96
THE EFFECT OF A TELEPHONE COUNSELING INTERVENTION BY PHARMACIST ON PATIENTS' BELIEFS ABOUT MEDICINES AND BLOOD PRESSURE CONTROL 96
GENDER DIFFERENCES IN MEDICATION TAKING BEHAVIOUR: A CASE OF OSTEOPOROSIS 96
THE USE OF REAL WORLD DATA TO BUILD ECONOMIC MODELS: A CASE STUDY OF OSTEOPOROSIS 96
A pragmatic controlled trial to improve the appropriate prescription of drugs in adult outpatients: Design and rationale of the EDU.RE.DRUG study 96
Analysis of Prescribing Patterns of Atypical Antipsychotics in Lhu Caserta 95
DIFFERENZE DI GENERE NELL???USO DEI FARMACI. ANALISI DEI DATI DI PRESCRIZIONE FARMACEUTICA IN ITALIA 95
Doctors commitment and long-term effectiveness for cost containment policies: lesson learned from biosimilar drugs 95
Longitudinal Trajectory Modeling to Assess Adherence to Sacubitril/Valsartan among Patients with Heart Failure 94
Aspetti epidemiologici ed economici del diabete in Campania: analisi dei dati di prescrizione attraverso farmaci traccianti 94
La gestione della malattia acido correlata nella medicina di primo livello. Sinergie di utilizzo degli archivi informatizzati per l’informatizzati per l’informazione e la formazione e la formazione professione. 94
Proton pump inhibitors market in primary care setting. 94
Treatment Patterns And Drug-Related Costs For Patients with Psoriasis on Biologic Therapy: A Retrospective Cohort Study In Southern Italy 94
Comorbidity in an Older Population with Type-2 Diabetes Mellitus: Identification of the Characteristics and Healthcare Utilization of High-Cost Patients 94
Drug-utilisation profiles and COVID-19 94
Evaluation of Factors Associated With Appropriate Drug Prescription and Effectiveness of Informative and Educational Interventions-The EDU.RE.DRUG Project 93
Valutazione dell'impatto sulla spesa farmaceutica dell'organizzazione logistica 93
Treatment patterns and medication adherence among newly diagnosed patients with migraine: a drug utilisation study 93
Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA 92
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 1) 91
Cost-effectiveness of treatment optimisation with biomarkers for immunotherapy in solid tumours: A systematic review protocol 91
Development and validation of a clinical risk score to predict the risk of SARS-CoV-2 infection from administrative data: A population-based cohort study from Italy 91
Valutazione economica dello studio CARDS 90
Predictors of new oral anticoagulant drug initiation as opposed to warfarin in elderly adults: A retrospective observational study in Southern Italy 90
THU0504 Utilisation of anti-osteoporotic drugs in real-world data: a study of gender-related differences 90
PSY90 - RETROSPECTIVE ANALYSIS OF ADMINISTRATIVE DATA TO ASSESS ADHERENCE, PHARMACOUTILIZATION AND COSTS OF BIOLOGICAL THERAPY TREATMENT OF PSORIASIS IN SOUTHERN ITALIAN SETTING 90
Prevalence and Characterization of Potential PPI-Clopidogrel Interaction in a Prescription Database in 2006-2009 90
Gender-Related Behaviors in Drug Consumption In Italy 89
Persistence at one year with antiosteoporotic drugs in Southern Italy: analysis of administrative databases. 89
Persistence with antiosteoporotic drugs: a retrospective population-based color study. 89
Biological therapy utilization, switching, and cost among patients with psoriasis: Retrospective analysis of administrative databases in southern Italy 89
THU0503 Cost analysis of anti-osteoporotic drugs in real-world clinical practice 89
Assessment of Patterns of Initiation of Oral Anticoagulant Therapy in Hypertensive Patients with Atrial Fibrillation 89
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 2) 89
Pharmacoeconomic consequences of losartan therapy in patients undergoing Diabetes End-Stage Renal Disease. 88
The European Innovation Partnership on Active and Healthy Ageing Synergies: Protocol for a Prospective Observational Study to Measure the Impact of a Community-Based Program on Prevention and Mitigation of Frailty (ICP - PMF) in Community-Dwelling Older Adults 88
The value of the polypill in cardiovascular disease: an Italian multidisciplinary Delphi panel consensus 88
Adaptation of communication assessment tool for community pharmacists in medication adherence and minor diseases management 87
Persistence as a robust indicator of medication adherence-related quality and performance 87
Changes in multimorbidity and polypharmacy patterns in young and adult population over a 4-year period: A 2011–2015 comparison using real-world data 87
Cost effectiveness analysis of bisoprolol treatment for heart failure 86
Assessment and potential determinants of compliance and persistence to antiosteoporosis therapy in Italy 86
Inappropriate medication prescribing among elderly patients in Italy 86
Initial Therapy, Regimen Change, and Persistence in a Spanish Cohort of Newly Treated Type 2 Diabetes Patients: A Retrospective, Observational Study Using Real-World Data 85
Consumption of biosimilar drugs in Campania Region for the years 2008-2011 84
Self-Assessment of Adherence to Medication: A Case Study in Campania Region Community-Dwelling Population 84
2019 ARIA Care pathways for allergen immunotherapy 84
THU0474 Utilisation of anti-osteoporotic drugs in real-world data: an analysis of persistence to therapy and risk of fracture 84
Developing and piloting a communication assessment tool assessing patient perspectives on communication with pharmacists (CAT-Pharm) 84
MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence 82
PERSISTENCE TO THERAPY AND THE ASSOCIATED RISK OF FRACTURES WITH ANTIOSTEOPOROTIC DRUGS 82
Totale 10.100
Categoria #
all - tutte 54.346
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.346


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021305 0 0 0 0 0 130 20 14 35 19 20 67
2021/20221.000 8 3 11 1 9 44 4 28 131 83 237 441
2022/20231.286 193 79 41 61 125 133 3 97 168 281 76 29
2023/20241.084 36 154 181 82 64 100 19 112 17 68 189 62
2024/20255.548 266 267 19 58 234 382 565 360 366 568 1.989 474
2025/20265.933 1.142 663 990 1.070 1.819 249 0 0 0 0 0 0
Totale 16.409